Amgen (AMGN) Reports Phase 3 CodeBreaK 200 trial of Lumakras Met Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. MRK
6. HTZ
7. INFY
8. HONA
9. TTWO
10. USO

Go back to Amgen (AMGN) Reports Phase 3 CodeBreaK 200 trial of Lumakras Met Primary Endpoint
Amgen Inc (NASDAQ: AMGN) Delayed: 347.01 --0 (-0%)
Previous Close $347.01    52 Week High $176.85 
Open $347.01    52 Week Low $133.64 
Day High $347.01    P/E 52.26 
Day Low $347.01    EPS $6.64 
Volume 1,876